Inspire Medical Systems Financial Statements
NYSE: INSPHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Inspire Medical Systems revenue and earnings
In fiscal 2025, Inspire Medical Systems generated $912.0 million in revenue, up 13.6% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $145.4 million (+171.8% year over year), for a net margin of 15.9% versus a median of -11.0% in the prior 5 years. Gross margin was 85.4% (up from 84.7%) and operating margin 5.6%.
Diluted earnings per share came in at $4.89, up from $1.75. Over the last 5 fiscal years, INSP's revenue has grown at a 51.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Inspire Medical Systems income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 911.98M | 802.80M | 624.80M | 407.86M | 233.39M | 115.38M | 82.05M | 50.59M | 28.57M |
| Revenue growth (YoY) | +13.60% | +28.49% | +53.19% | +74.75% | +102.28% | +40.62% | +62.18% | +77.10% | — |
| Cost of Revenue | 133.22M | 122.99M | 96.58M | 66.11M | 33.28M | 17.62M | 13.64M | 10.06M | 6.02M |
| Gross Profit | 778.76M | 679.82M | 528.22M | 341.74M | 200.12M | 97.76M | 68.41M | 40.54M | 22.55M |
| Operating Expenses | 727.80M | 643.74M | 568.49M | 389.33M | 239.97M | 153.97M | 103.30M | 60.91M | 38.55M |
| Research & Development | 103.17M | 114.13M | 116.54M | 68.64M | 37.35M | 26.09M | 12.84M | 7.39M | 6.19M |
| Selling, General & Admin | 624.64M | 529.61M | 451.96M | 320.69M | 202.62M | 127.87M | 90.47M | 53.53M | 32.36M |
| Operating Income | 50.95M | 36.08M | -40.27M | -47.59M | -39.85M | -56.21M | -34.90M | -20.38M | -16.00M |
| Interest Expense | 137.00K | 22.00K | 0 | 1.68M | 2.13M | 2.12M | 2.12M | 3.30M | 1.75M |
| Other Income (Expense) | 14.74M | 22.37M | 20.36M | 3.32M | -2.12M | -880.00K | 1.69M | -1.45M | -1.51M |
| Pretax Income | 65.70M | 58.45M | -19.91M | -44.27M | -41.97M | -57.09M | -33.20M | -21.83M | -17.51M |
| Income Tax | -79.72M | 4.94M | 1.25M | 613.00K | 72.00K | 115.00K | 40.00K | 0 | 0 |
| Net Income | 145.42M | 53.51M | -21.15M | -44.88M | -42.04M | -57.20M | -33.24M | -21.83M | -17.51M |
| Net Income growth (YoY) | +171.77% | — | — | — | — | — | — | — | — |
| EPS (Basic) | 4.95 | 1.80 | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 | -1.50 | -14.88 |
| EPS (Diluted) | 4.89 | 1.75 | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 | -1.50 | -14.88 |
| Shares Outstanding (Basic) | 29.37M | 29.76M | 29.30M | 28.07M | 27.26M | 26.07M | 23.80M | 14.58M | 1.18M |
| Shares Outstanding (Diluted) | 29.76M | 30.54M | 29.30M | 28.07M | 27.26M | 26.07M | 23.80M | 14.58M | 1.18M |
| EBITDA | 64.91M | 42.63M | -37.42M | -45.73M | -38.63M | -55.37M | -34.40M | -19.98M | -15.72M |
| Gross Margin | 85.39% | 84.68% | 84.54% | 83.79% | 85.74% | 84.73% | 83.37% | 80.12% | 78.93% |
| Operating Margin | 5.59% | 4.49% | -6.45% | -11.67% | -17.07% | -48.72% | -42.53% | -40.28% | -56.02% |
| Net Margin | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% | -49.58% | -40.52% | -43.14% | -61.30% |
This table shows 9 annual periods of Inspire Medical Systems's income statement, from FY 2025 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow INSP's reporting calendar. What is a income statement?